Abionyx Pharma SA
Research Abionyx Pharma SA (ABNX) on Bullrun: market cap EUR 72.00M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerABNX
- ExchangePA
- CountryFrance
- SectorHealthcare
- IndustryBiotechnology
- CurrencyEUR
- Market capEUR 72.00M
- Financial periodFY2025
- RevenueEUR 4.06M
- Revenue growth-10.7%
- Net income-EUR 5.55M
- Free cash flow-EUR 3.18M
- Gross margin13.1%
Valuation Snapshot
latest market cap is EUR 72.00M.
About Abionyx Pharma SA
ABIONYX Pharma SA, a biotech company, discovers and develops therapies for the treatment of renal, metabolic, and ophthalmic diseases in France and the United States. It operates through Research and Development Activities for the Development of Innovative Drugs; and Contract Research Organization (CRO) Activities segments.
Frequently asked questions
What is Abionyx Pharma SA's market cap?
Abionyx Pharma SA's market capitalization is EUR 72.00M.
What does Abionyx Pharma SA do?
ABIONYX Pharma SA, a biotech company, discovers and develops therapies for the treatment of renal, metabolic, and ophthalmic diseases in France and the United States. It operates through Research and Development Activities for the Development of Innovative Drugs;